SNSS - Sunesis Pharmaceuticals EPS beats by $0.01 August, 07 2019 04:16 PM Viracta Therapeutics Inc Com Sunesis Pharmaceuticals (NASDAQ:SNSS): Q2 GAAP EPS of -$0.09 beats by $0.01.More news on: Sunesis Pharmaceuticals, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...